Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma

Fig. 5

METTL3 affects the FGFR3 expression and antitumor efficacy of anlotinib in PDX models. A–D Representative H&E staining and IHC staining of METTL3, FGFR3 and p-FGFR3 in PDX models. #005 represented highest TGI rate (95.9%); #022 represented lowest TGI rate (78.07%). E The correlation between the IHC score of METTL3 and TGI rate, IHC score of FGFR3 and TGI rate, IHC score of METTL3 and FGFR3, IHC score of METTL3 and p-FGFR3

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us